Double-stranded RNA induces MMP-9 gene expression in HaCaT keratinocytes by tumor necrosis factor-α

Andreas Voss1, Kirsten Gescher, Andreas Hensel

  • 1Institute of Immunology, Helmholtz Centre for Infection Research, Inhoffenstr 7, D-38124 Braunschweig, Germany.

Insights

Poly (I:C) triggers matrix metallo-proteinase-9 (MMP-9) expression in skin cells via specific signaling pathways. This finding is crucial for understanding inflammation and tissue injury during antiviral responses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Dermatology

Background:

  • Viral double-stranded RNA (dsRNA) and its analog poly (I:C) are recognized by cellular pathways, initiating inflammatory gene expression.
  • Matrix metallo-proteinases (MMPs) play roles in tissue remodeling and inflammation.

Purpose of the Study:

  • To investigate the specific induction of matrix metallo-proteinase-9 (MMP-9) by poly (I:C) in HaCaT keratinocytes.
  • To elucidate the signaling pathways and cellular mechanisms involved in poly (I:C)-induced MMP-9 expression.

Main Methods:

  • HaCaT keratinocytes were treated with poly (I:C).
  • Pharmacological inhibitors targeting NF-κB, p38 MAPK, PI-3K, vacuolar H(+)-ATPase (bafilomycin A1), and lysosomes (chloroquine) were used.
  • Cycloheximide was employed to assess protein synthesis dependence.
  • TNFα stimulation was performed to evaluate its effect on MMP-9 expression.

Main Results:

  • Poly (I:C) specifically induced MMP-9 gene expression in HaCaT keratinocytes.
  • NF-κB, p38 MAPK, and PI-3K signaling pathways were involved in this induction.
  • MMP-9 induction was sensitive to bafilomycin A1 and chloroquine, suggesting involvement of vacuolar and lysosomal pathways.
  • Cycloheximide partially inhibited MMP-9 expression, indicating a role for de novo protein synthesis.
  • TNFα significantly promoted poly (I:C)-induced MMP-9 gene expression.

Conclusions:

  • Poly (I:C) induces MMP-9 expression in keratinocytes through NF-κB, p38 MAPK, and PI-3K signaling.
  • Vacuolar/lysosomal pathways and partial protein synthesis dependence are implicated in MMP-9 induction.
  • TNFα plays a key role in amplifying MMP-9 expression.
  • MMP-9 may contribute to tissue injury during antiviral responses.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...